Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

Cannabidiol and (−)Δ ⁹ -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850 · see citing works

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works

History of cannabis as a medicine: a review.

Zuardi, A. (2006) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462006000200015 · Cited by 581 · see citing works

Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients

Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570 · see citing works

Oxidative stress markers in bipolar disorder: A meta-analysis

Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526 · see citing works

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465 · see citing works

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.009 · Cited by 407 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 402 · see citing works

Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · cited 1× · see citing works

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364 · see citing works

Neuroprotective effect of cannabidiol, a non‐psychoactive component from<i>Cannabis sativa</i>, on β‐amyloid‐induced toxicity in PC12 cells

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., & Izzo, A. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02327.x · Cited by 361 · see citing works

Cannabidiol for the treatment of psychosis in Parkinson's disease

Zuardi, A., Crippa, J., Hallak, J., Pinto, J., Chagas, M., Rodrigues, G., Dursun, S., & Tumas, V. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108096519 · Cited by 355 · see citing works

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

García-Arencibia, M., González, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.063 · Cited by 320 · see citing works

Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects

Machado‐Vieira, R., Andreazza, A. C., Viale, C. I., Zanatto, V. C., Ceresér, V. H., Vargas, R. D. S., Kapczinski, F. P., Portela, L. V., Souza, D. O., Salvador, M. M., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.016 · Cited by 314 · see citing works

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312 · see citing works

Cannabidiol <i>in vivo</i> blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308 · see citing works

Effects of cannabidiol (CBD) on regional cerebral blood flow

Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307 · see citing works

The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 252 · see citing works

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

Frey, B. N., Andreazza, A. C., Ceresér, K. M. M., Martins, M. R., Valvassori, S. S., Réus, G. Z., Quevedo, J., & Kapczinski, F. P. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.002 · Cited by 239 · see citing works

Effects of lithium and valproate on amphetamineinduced oxidative stress generation in an animal model of mania

Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0637 · Cited by 238 · see citing works

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement

Esposito, G., De Filippis, D., Maiuri, M. C., De Stefano, D., Carnuccio, R., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.047 · Cited by 225 · see citing works

Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.

Goodwin, F. K. (2003) · PubMed · Cited by 210 · see citing works

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207 · see citing works

Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition

Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Fraccaro, V., Atakan, Z., Martin-Santos, R., O'Carroll, C., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.011 · Cited by 195 · see citing works

Cannabidiol monotherapy for treatment-resistant schizophrenia

Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060967 · Cited by 192 · see citing works

Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity

Hamelink, C., Hampson, A. J., Wink, D. A., Eiden, L. E., & Eskay, R. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085779 · Cited by 190 · see citing works

Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid<i>in vivo</i>by mechanisms independent of the activation of cannabinoid, vanilloid TRPV₁and adenosine A_2Areceptors

Sagredo, O., Ramos, J. A., Decio, A., Mechoulam, R., & Fernández‐Ruiz, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05717.x · Cited by 147 · see citing works

Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users

Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., & Mann, K. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.027 · Cited by 135 · see citing works

Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents

Carlini, E. A., Leite, J. R., Tannhauser, M., & Berardi, A. C. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10660.x · Cited by 125 · see citing works

Effect of cannabidiol and of other Cannabis sativa compounds on hippocampal seizure discharges

Izquierdo, I., Orsingher, O. A., & Berardi, A. C. (1973) · Psychopharmacology · doi:10.1007/bf00413961 · Cited by 110 · see citing works

Hypnoticlike effects of cannabidiol in the rat

Monti, J. M. (1977) · Psychopharmacology · doi:10.1007/bf00497858 · Cited by 84 · see citing works

GABA-Ergic Drugs: Exit Stage Left, Enter Stage Right

Ashton, H., & Young, A. H. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002004 · Cited by 80 · see citing works

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum

Guimaraes, V. H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.015 · Cited by 75 · see citing works

Cannabidiol was ineffective for manic episode of bipolar affective disorder

Zuardi, A., Crippa, J., Dursun, S., Morais, S., Vilela, J., Sanches, R., & Hallak, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108096521 · Cited by 72 · see citing works

Anticonvulsant properties of cannabidiol.

Turkanis, S. A., Cely, W., Olsen, D. M., & Karler, R. (1974) · PubMed · Cited by 59 · see citing works

Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology

Bhattacharyya, S., Crippa, J. A., Martín‐Santos, R., Winton‐Brown, T., & Fusar‐Poli, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788957465 · Cited by 52 · see citing works

Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro

Kuhlmann, C. R. W., Gerigk, M., Bender, B., Closhen, D., Leßmann, V., & Luhmann, H. J. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.017 · Cited by 47 · see citing works

Schizandrin Protects Primary Cultures of Rat Cortical Cells From Glutamate-Induced Excitotoxicity

Cheng, H., Hsieh, M., Wu, C., Tsai, F.-H., Lu, T.-C., Hsieh, C., Li, W.-C., Lin, Y., & Peng, W. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0072394 · Cited by 39 · see citing works

Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.

Zuardi, A. W., & Karniol, I. G. (1983) · PubMed · Cited by 38 · see citing works

Anticonvulsants as mood stabilisers

Porter, R., Ferrier, N., & Ashton, H. (1999) · Advances in Psychiatric Treatment · doi:10.1192/apt.5.2.96 · Cited by 14 · see citing works

Impact of formularies on clinical innovation.

Goodwin, F. K. (2003) · PubMed · Cited by 11 · see citing works

Emerging drugs for bipolar disorder

Mitchell, P. B., & Malhi, G. S. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.4.621 · Cited by 5 · see citing works

Antioxidative and Anti-Inflammatory Properties of Cannabidiol

Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 839 · see citing works

An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies

Iffland, K., & Grotenhermen, F. (2017) · Cannabis &amp; Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645 · see citing works

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works

Cannabidiol, neuroprotection and neuropsychiatric disorders

Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446 · see citing works

Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age

Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

Booz, G. W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.007 · Cited by 246 · see citing works

The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders

Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190903103923 · Cited by 227 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · see citing works

Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings

Elsaid, S., Kloiber, S. M., & Foll, B. L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.005 · Cited by 136 · see citing works

Cannabidiol as a potential treatment for psychosis

Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 113 · see citing works

Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments

Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.006 · Cited by 97 · see citing works

Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria

Campos, A. C., Brant, F., de Miranda, A. S., Machado, F. S., & Teixeira, A. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.051 · Cited by 93 · see citing works

Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test

de Almeida, V., Levin, R. R., Peres, F. F., Niigaki, S. T., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., & Abílio, V. C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.024 · Cited by 90 · see citing works

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala

Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86 · see citing works

Uso terapêutico dos canabinoides em psiquiatria

Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500009 · Cited by 85 · see citing works

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms

Calpe-López, C., García-Pardo, M. P., & Aguilar, M. A. (2019) · Molecules · doi:10.3390/molecules24142583 · Cited by 76 · see citing works

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Peres, F. F., Levin, R. R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., de Almeida, V., Santos, C. M., Lungato, L., Zuardi, A. W., Hallak, J. E. C., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00343 · Cited by 77 · see citing works

Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

Norris, C., Loureiro, M., Kramar, C. P., Zunder, J. S., Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.93 · Cited by 75 · see citing works

Review: Cannabinoids as Medicinals

Khalsa, J. H., Bunt, G. C., Blum, K., Maggirwar, S. B., Galanter, M. S., & Potenza, M. N. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00438-3 · Cited by 72 · see citing works

Neutrophil-Biomimetic “Nanobuffer” for Remodeling the Microenvironment in the Infarct Core and Protecting Neurons in the Penumbra via Neutralization of Detrimental Factors to Treat Ischemic Stroke

Liu, S., Xu, J., Liu, Y., You, Y., Xie, L., Tong, S., Chen, Y., Liang, K., Zhou, S., Li, F., et al. (2022) · ACS Applied Materials &amp; Interfaces · doi:10.1021/acsami.2c09020 · Cited by 58 · see citing works

Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration

Maurya, S. K., Bhattacharya, N., Mishra, S., Bhattacharya, A., Banerjee, P., Senapati, S., & Mishra, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654489 · Cited by 58 · see citing works

Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

Jîtcă, G., Ősz, B. E., Vari, C.-E., Rusz, C.-M., Tero-Vescan, A., & Puşcaş, A. (2023) · Antioxidants · doi:10.3390/antiox12020485 · Cited by 54 · see citing works

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain

Valvassori, S. S., Bavaresco, D. V., Scaini, G., Varela, R. B., STRECK, E. L., Chagas, M. H. N., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0886 · Cited by 51 · see citing works

Effects of alpha‐lipoic acid in an animal model of mania induced by d ‐amphetamine

Macêdo, D. S., Medeiros, C. D., Cordeiro, R. C., de Sousa, F. C. F., Santos, J. V. D., Morais, T. A., Hyphantis, T. N., McIntyre, R. S., Quevedo, J., & Carvalho, A. F. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01046.x · Cited by 50 · see citing works

Patient-Reported Symptom Relief Following Medical Cannabis Consumption

Stith, S. S., Vigil, J. M., Brockelman, F., Keeling, K., & Hall, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00916 · Cited by 50 · see citing works

Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. D. A., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., Costa, K. C. M., Campos, A. C., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06196-4 · Cited by 52 · see citing works

Emerging potential of cannabidiol in reversing proteinopathies

Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 49 · see citing works

The effectiveness of self-directed medical cannabis treatment for pain

Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.07.022 · Cited by 45 · see citing works

The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia

Arnold, J. C., Boucher, A. A., & Karl, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884726 · Cited by 43 · see citing works

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury

Soares, R. Z., Vuolo, F. S., Dall’Igna, D. M., Michels, M., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., & Dal‐Pizzol, F. (2015) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20150064 · Cited by 40 · see citing works

Cannabis and multiple sclerosis

Ingram, G., & Pearson, O. R. (2019) · Practical Neurology · doi:10.1136/practneurol-2018-002137 · Cited by 37 · see citing works

UNIVERSIDADE DO EXTREMO SUL CATARINENSE - UNESC

Saúde, U. A. D., & Rosa, J. L. N. D. (2011) · Cited by 36 · see citing works

Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique

Pinto, J. V., Saraf, G., Frysch, C., Vigo, D., Keramatian, K., Chakrabarty, T., Lam, R. W. M., Kauer‐Sant’Anna, M., & Yatham, L. N. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719895195 · Cited by 36 · see citing works

Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH

da-Rosa, D. D., Valvassori, S. S., Steckert, A. V., Ornell, F. R., Ferreira, C. L., Lopes-Borges, J., Varela, R. B., Dal‐Pizzol, F., Andersen, M. L., & Quevedo, J. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.019 · Cited by 34 · see citing works

Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models

van Enkhuizen, J., Geyer, M. A., Minassian, A., Perry, W., Henry, B. L., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.008 · Cited by 31 · see citing works

Could cannabidiol be used as an alternative to antipsychotics?

Fakhoury, M. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.05.013 · Cited by 32 · see citing works

Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2014.03.005 · Cited by 31 · see citing works

Neuroprotection Following Concussion: The Potential Role for Cannabidiol

Singh, J., & Neary, J. P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.23 · Cited by 30 · see citing works

Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol

Kajero, J. A., Seedat, S., OHAERI, J. U., Akindele, A. J., & Aina, O. O. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1752934 · Cited by 22 · see citing works

Global Trends in Cannabis and Cannabidiol Research from the Year 1940 to 2019

Liu, J., Chen, H., Newmaster, S. G., Wang, S., & Liu, C. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200601152118 · Cited by 22 · see citing works

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

Umpierrez, L. S., Costa, P. A., Michelutti, E. A., Baracz, S. J., Sauer, M. K., Turner, A. J., Everett, N. A., Arnold, J. C., McGregor, I. S., & Cornish, J. L. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06119-3 · Cited by 20 · see citing works

Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice

Ledesma, J. C., Manzanedo, C., & Aguilar, M. A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110390 · Cited by 20 · see citing works

Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência

Diehl, A., Cordeiro, D. C., & Laranjeira, R. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500007 · Cited by 19 · see citing works

Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models

Jenkins, B. W., & Khokhar, J. Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.597725 · Cited by 18 · see citing works

Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

Daldegan‐Bueno, D., Maia, L. O., Glass, M., Jutras‐Aswad, D., & Fischer, B. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05960-2 · Cited by 18 · see citing works

Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine

Brakatselos, C., Delis, F., Asprogerakas, M.-Z., Lekkas, P., Tseti, I. K., Tzimas, P. S., Petrakis, E. A., Halabalaki, M., Skaltsounis, A., & Antoniou, K. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.029 · Cited by 16 · see citing works

A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders

Omotayo, O. P., Lemmer, Y., & Mason, S. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00222-2 · Cited by 18 · see citing works

The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects

Kotańska, M., Kubacka, M., Bednarski, M., Nicosia, N., Szafarz, M., Jawień, W., Müller, C. E., & Kieć‐Kononowicz, K. (2021) · Pharmaceuticals · doi:10.3390/ph14080799 · Cited by 14 · see citing works

The antimanic‐like effect of phenytoin and carbamazepine on methylphenidate‐induced hyperlocomotion: role of voltage‐gated sodium channels

Tonelli, D. A. G., Pereira, M., Siba, I. P., Martynhak, B. J., Correia, D., Casarotto, P. C., Biojone, C., Guimarães, F. S., Joca, S. R. L., & Andreatini, R. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12022 · Cited by 14 · see citing works

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model

García‐Gutiérrez, M. S., Navarro, D., Austrich-Olivares, A., & Manzanares, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1171646 · Cited by 12 · see citing works

Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania

Menegas, S., Ferreira, C. L., Cararo, J. H., Gava, F. F., Dal-Pont, G. C., Gomes, M. L., Agostini, J. F., Schuck, P. F., Scaini, G., Andersen, M. L., et al. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00408-1 · Cited by 12 · see citing works

The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice

Ghavimi, H., Ershadi, A. S. B., Dastvar, S., & Hosseini, M. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1942484 · Cited by 11 · see citing works

Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats

Brakatselos, C., Polissidis, A., Ntoulas, G., Asprogerakas, M.-Z., Tsarna, O., Vamvaka-Iakovou, A., Nakas, G., Delis, A. D., Tzimas, P., Skaltsounis, A., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01977-1 · Cited by 10 · see citing works

Medicinal uses of Cannabis sp.

de Souza, A. A. F., da Silva, A. F. M., de Abreu, L. R., da Silva, T. F., Greco, G. L. C., Santos, S. D. S., & Gonzaga, R. V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16930 · Cited by 11 · see citing works

The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review

Walter, T. J., Pocuca, N., Young, J. W., Geyer, M. A., Minassian, A., & Perry, W. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113695 · Cited by 10 · see citing works

Cannabidiol effect on long-term brain alterations in septic rats: Involvement of PPARγ activation

Gava, F. F., Carli, R. J. D., Stork, S. D. S., Danielski, L. G., Bonfante, S., Joaquim, L. D. S., Metzker, K. L. L., Mathias, K., dos Santos, D., Daros, G. C., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148771 · Cited by 9 · see citing works

CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration

Poulia, N., Delis, F., Brakatselos, C., Ntoulas, G., Asprogerakas, M.-Z., & Antoniou, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746935 · Cited by 9 · see citing works

Therapeutic potential of CBD in Autism Spectrum Disorder

Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 11 · see citing works

Cannabis e humor

Sanches, R. F., & Marques, J. M. D. A. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000200014 · Cited by 9 · see citing works

Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone

Kajero, J. A., Seedat, S., OHAERI, J. U., Akindele, A. J., & Aina, O. O. (2022) · Scientific Reports · doi:10.1038/s41598-022-24235-0 · Cited by 8 · see citing works

The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration

Kajero, J. A., Seedat, S., OHAERI, J. U., Akindele, A. J., & Aina, O. O. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.29 · Cited by 6 · see citing works

Effects of Cannabidiol Isolated or in Association With Risperidone in an Animal Model of Autism

da Costa, M. D. A., Fernandes, G. Z., Maiochi, E., Ebs, M. F. P., Darós, F. D. S., Bolan, S. J., Costa, R. R. N., de Rezende, V. L., da Silva, G. C., de Bitencourt, R. M., et al. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22955 · Cited by 8 · see citing works

The Role of Cannabis within an Emerging Perspective on Schizophrenia

Diviant, J. P., Vigil, J. M., & Stith, S. S. (2018) · Medicines · doi:10.3390/medicines5030086 · Cited by 5 · see citing works

Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients

Alasmari, F. F., Alsanea, S., Alfadda, A. A., Alanazi, I. O., Musambil, M., Masood, A., Alqahtani, F., Fantoukh, O. I., Alasmari, A. F., & Benabdelkamel, H. (2021) · Molecules · doi:10.3390/molecules26175311 · Cited by 5 · see citing works

Cannabidiol Modulating the Expression of Neurotrophin Signaling Pathways in Chronic Exposure to Methamphetamine in Rats During Abstinence Period

Razavi, Y., Najafi, M., Haghparast, A., Keyhanfar, F., Shabani, R., & Mehdizadeh, M. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.3059.1 · Cited by 4 · see citing works

Behavioral manifestations and underlying mechanisms of amphetamine in constructing animal models of mania: a comprehensive review

Deng, Z.-Q., Si, X.-C., Song, J., Li, J., Sun, L., Dang, X., Zhao, M., Feng, Y.-C., & Liu, F.-X. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1544311 · Cited by 3 · see citing works

The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms

Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3 · see citing works

Roles of Cannabidiol in Reversing ProteinopathiesPreprint

Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Preprints.org · doi:10.20944/preprints202005.0340.v1 · Cited by 3 · see citing works

The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation

Velickovic, U., Selaković, D., Jovicic, N. U., Mitrović, M. M., Janjic, V. S., Rosic, S., Randjelovic, S., Milovanovic, D., & Rosic, G. L. (2025) · Biomedicines · doi:10.3390/biomedicines13020512 · Cited by 2 · see citing works

Cannabidiol Pretreatment Reduces Status Epilepticus and Glutamate Uptake Induced by Kainic Acid in Adult Zebrafish

Pickler, K. D. P., de Farias, A. C. S., Lodetti, G., Bernardo, H. T., Baldin, S. L., Dondossola, E. R., Hallak, J. E. C., Crippa, J. A. S., Cararo, J. H., Budni, J., et al. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0189 · Cited by 1 · see citing works

THERAPEUTIC POTENTIAL OF CANNABIDIOL: THE MOST IMPORTANT ACHIEVEMENTS ON THE WAY TO A NEW ERA

Shevchuk, M. M., & Volos, L. I. (2023) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.2.2023.17 · Cited by 1 · see citing works

Cannabis abuse in patients with psychiatric disorders: an update to old evidence Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência

Diehl, A., Cordeiro, D. C., & Laranjeira, R. (2010)

Mecanismos envolvidos no perfil antipsicótico do canabidiol

Pedrazzi, J. F. C. (2019) · doi:10.11606/t.17.2019.tde-30042019-163956

Efeitos agudos centrais do canabidiol por meio de neuroimagem funcional e sobre o reconhecimento de emoções faciais em pacientes com transtorno depressivo maior

Zamarrenho, L. G. (2020) · doi:10.11606/t.17.2020.tde-23082020-104553

Neuroprotective Effects of Cannabidiol Following Concussion: A Case Study

Singh, J. (2019) · oURspace (University of Regina) · doi:10.82465/6521

Cannabidiol improves short-term memory in a Streptozotocin-induced animal model of Alzheimer’s diseasePreprint

Pereira, G. C., Silva, V. A., Soares‐Silva, B., Taliano, L. O., Carvalhinho-Lopes, P. S., Custódio‐Silva, A. C., Silva, E., Lambertucci, R. H., Abílio, V. C., dos Santos, J. R., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7197783/v1

Perinatal cannabinoid exposure

Iezzi, D., & Manzoni, O. J. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00014-1

Beta-Caryophyllene Prevents Ouabain-Induced Neurodegeneration and Behavioral Alterations Through PKA/GSK-3β Pathway

Guerra, J. M. D. S., Souza-Pereira, A., Maidana, L. M., Lins, M. P., Pereira, G. L. M., Dahleh, M. M. M., Prigol, M., Furian, A. F., Oliveira, M. S., & Rambo, L. M. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04843-2

Cannabidiol Ameliorates Blood–Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness‐Like Behaviors

Chen, Y., Ma, H., Long, Q., Fang, X., Li, X., Xiao, W., Deng, X., Du, F., Tan, Y., Wang, Y., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71168

Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats

Metz, V. G., da Rosa, J. L. O., Rossato, D. R., Milanesi, L. H., Bürger, M. E., & Pase, C. S. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.008 · Cited by 20 · see citing works

Cannabidiol treatment prevents drug reinstatement and the molecular alterations evoked by amphetamine on receptors and enzymes from dopaminergic and endocannabinoid systems in rats

Metz, V. G., da Rosa, J. L. O., Rossato, D. R., Bürger, M. E., & Pase, C. S. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173427 · Cited by 5 · see citing works

Doxycycline reversal of amphetamine-induced mania-like behavior is related to adjusting brain monoamine abnormalities and antioxidant effects in primary hippocampal neurons

Chaves-Filho, A. J. M., Soares, M. V.-R., Jucá, P. M., Oliveira, T. D. Q., Clemente, D. C. D. S., Monteiro, C. E. D. S., Silva, F. G. O., de Aquino, P. É. A., & Macêdo, D. S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03009-7 · Cited by 1 · see citing works

Protein Kinase C and Oxidative Stress in an Animal Model of Mania

Steckert, A. V., Valvassori, S. S., Mina, F., Lopes-Borges, J., Varela, R. B., Kapczinski, F. P., Dal‐Pizzol, F., & Quevedo, J. (2012) · Current Neurovascular Research · doi:10.2174/156720212799297056 · Cited by 32 · see citing works

Cannabidiol attenuates methamphetamine-induced psychosis via anti-oxidative stress: σ1R-mediated mitochondrial dysfunction as a critical pathway

Liu, L., Wang, C., Tian, Y., Yin, Y., Rao, M., Tao, H., Luo, C., Li, J., & Zeng, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158015 · Cited by 1 · see citing works